Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1992-07-15
1995-06-06
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
530350, 530380, 530381, 514 12, C07K 1300
Patent
active
054220904
ABSTRACT:
Minactivin (also known as Plasminogen Activator Inhibitor-2 [PAI-2]), a protein inactivator of urokinase-type plasminogen activator, has been shown to be a natural inactivator of this plasminogen activator which is associated with invasive tumors, and is therefore indicated as a crucial element in the body's normal defense against tumor invasion and metastasis. It may be produced by the cultivation of minactivin-producing cells in vitro, and recovery of the cell culture supernatant. By controlling the culture conditions, the protein minactivin may be produced in a partially purified form which may be used for diagnosis and treatment of tumors. The specification discloses purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences. The specification also discloses methods for production of PAI-2 by recombinant DNA technology, characterization of a PAI-2 gene sequence, and expression and purification of large quantities of biologically active PAI-2 from a recombinant host.
REFERENCES:
patent: 4632981 (1986-12-01), Bock
patent: 4711848 (1987-12-01), Insley et al.
patent: 4849349 (1989-07-01), Ragg et al.
patent: 4923807 (1990-05-01), Webb et al.
patent: 4952512 (1990-08-01), Loskutoff
patent: 5028534 (1991-07-01), Sadler et al.
Aoki et al., "Inhibition of Plasminogen Activators by Naturally Occurring Inhibitors in Man", American Journal on Physiology, 1334-1447 (Dec. 1974).
Astedt et al., "Different Inhibition of One and Two Chain Tissue Plasminogen Activator by a Placental Inhibitor . . . ", Scand. J. Clin. Lab. Invest. 45: 429-435 (1985).
Astedt et al., "Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and its Complex Formation with Plasminogen Activator", Thrombosis & Haemostasis, 122-125 (1985).
Auron et al., "Nucleotide Sequence of Human Monocyte Interleukin 1 Precursor cDNA", Proc. Natl. Acad. Sci., 81:7907-7911 (1984).
Chapman et al., "Macrophage Fibrinolytic Activity: Identification of Two Pathways of Plasmin Formation by Intact Cells and of a Plasminogen Activagor Inhibitor", Cell, vol. 28: 653-662 (1982).
Chapman et al., "Characterization of a Macrophage-derived Plasminogen-activator Inhibitor", Biochem. J., 230:109-116 (1985).
Golder et al., "Minactivin: A Human Monocyte Product Which Specifically Inactivates Urokinase-type Plasminogen Activators", Eur. J. Biochem., 136:518-522 (1983).
Holmberg et al., "Purification of Urokinase by Affinity Chromatography", Biochem. of Biophysica Acta, 445:215-222 (1976).
Holmberg et al., "An Inhibitor from Placenta Specifically Binds Urokinase and Inhibits Plasminogen Activator Released from Ovarian Carcinoma . . . ", Biochimica et Biophysica Acta, 514:128-137 (1978).
Kruithof et al., "Partial Primary Structure of a PA Inhibitor Homologies with Other Serine Protease Inhibitors", 10th Int'l. Congress on Fibrinetysis, Vienna 1986.
Kruithof et al., "Purification and Characterization of a Fast-acting Inhibotor of Urokinase (UK) from the Histiocytic Lymphoma Cell-line U-937", 10th Int'l. Congress on Thrombosis & Haemotosis (1985).
Kruithof et al., "Partial Purification and Characterization of Plasminogen Activator Inhibitor (PAI-1) mRNA", 10th Int'l. Congress of Thrombosis & Haemotosis, 1985.
Kruithof et al., "Studies on Prourokinase and Plasminogen Activator Inhibitor Biosynthesis in Phorbol Ester Induced U-937", 10th Int'l. Congress of Thrombosis & Haemotosis, 1985.
Kruithof et al., "Purification and Characterization of a Plasminogen Activator Inhibitor from the Histiocytic Lymphoma Cell Line U-937", J. Biological Chem., 261(24):11207-11213 (1986).
Kopitar et al., "Human Leucocyte Urokinase Inhibitor--Purification Characterization and Comparative Studies Against Different Plasminogen Activators", Thrombosis & Haemostasis, 54(4):750-755 (1985).
Lecander et al., "Differential Inhibition of Two Molecular Forms of Melanoma Cell Plasminogen Activator by a Placental Inhibitor", British J. Haematology, 57:407-412 (1984).
Lecander et al., "Isolation of a New Specific Plasminogen Activator Inhibitor from Pregnancy Plasma", British J. Haematology, 62:221-228 (1986).
Philips et al., "Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells . . . ", Thrombosis & Haemostasis, 55(2):213-217.
Sakasela et al., "Urokinase-Type Plasminogen Activator and Its Inhibitor Secreted by Cultured Human Monocyte-Macrophages", J. Cellular Physiology, 132:122-125 (1985).
Van Mourik et al., "Purification of an Inhibitor of Plasminogen Activator (Antiactivator) Synthesized by Endothelial Cells", J. Biol. Chem., 259(23):14914-14921 (1984).
Vassalli et al., "Human Monocytes-Macrophages and U-937 Cells Synthesize and Secrete a Plasminogen Activator-Specific Protease Inhibitor", Abstract, 7th International Congress on Fibrinolysis, Venice, Italy, Mar. 27-30, 1984, Hemostasis, 14(1):95.
Vassalli et al., "Concomitant Secretion of Prourokinase and of a Plasminogen Activator-Specific Inhibitor by Cultured Human Monocytes-Macrophages", J. Exp. Med., 1653-1668 (1984).
Webb et al., "Sequence, Chromosomal Assignment, and Homology to Plasminogen Activator-Inhibitor", J. Exp. Med., 166:77-91 (1987).
Wohlwend et al., "Plasminogen Activator-Specific Inhibitors Produced by Human Monocytes/Macrophages", J. Exp. Med., 165:320-339 (1987).
Wun et al., "An Inhibitor of Plasminogen Activation from Human Placenta", J. Biol. Chem., 262(8):3546-3653 (1987).
Ye et al., "cDNA Cloning and Expression in Escherichia coli of a Plasminogen Activator Inhibitor from Human Placenta", J. Biol. Chem., 262(8):3718-3725 (1987).
Young et al., "Efficient Isolation of Genes by Using Antibody Probes", Proc. Natl. Acad. Sci., 80:1194-1198 (1983).
Antalis Toni M.
Barnes Thomas M.
Clark Michell A.
Devine Peter L.
Golder Jeffrey P.
Australian National University
Biotechnology Australia Pty. Ltd.
Brown Gary L.
Schwartz Richard A.
LandOfFree
Human PAI-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human PAI-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human PAI-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-985660